<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29847" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Histology, T-Cell Lymphocyte</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sauls</surname>
            <given-names>Ryan S.</given-names>
          </name>
          <aff>Lincoln Memorial Un- DeBusk College OM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>McCausland</surname>
            <given-names>Cassidy</given-names>
          </name>
          <aff>Columbus Central University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Taylor</surname>
            <given-names>Bryce N.</given-names>
          </name>
          <aff>Lincoln Memorial Un - DeBusk College OM</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ryan Sauls declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cassidy McCausland declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bryce Taylor declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29847.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>T cells are a diverse and important group of lymphocytes that mature and undergo a positive and negative selection processes in the thymus. These cells play a vital role in both components of active immunity, including cell-mediated and to some extent humoral immunity. There are several types of&#x000a0;T cells; the most common and well-known are the CD4+ T cells (helper T cells) and CD8+ T Cells (cytotoxic T cells, or killer T cells). T cells cannot recognize soluble, free antigens. T cells can only recognize protein-based, receptor-bound antigens. This recognition occurs via the use of the MHC (also known as HLA) 1 and 2 receptors, which along with the TCRs (T-cell receptors) bind the antigen in question and form a complex that allows the T cell to recognize the antigen. CD4+ T cells recognize MHC 2 bound antigens, while CD8+ T cells recognize MHC 1 bound antigens. Both CD4+ T cells and CD8+ T cells have the TCR (and the co-receptor CD3), but (as evidenced by their name) their other co-receptors vary. CD4+ T cells have CD4, whereas CD8+ T cells have CD8 as an added co-receptor. T cells are identified via flow cytometry for their CD markers as opposed to EM or light microscopy.</p>
      </sec>
      <sec id="article-29847.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>T-cell dysfunction is notable in several types of immunodeficiencies and autoimmune diseases, both acquired and genetic. Notably, T cells are the main targets of the human immunodeficiency virus and human T-lymphotropic virus. T cells are also implicated in several types of neoplasms, such as T-cell acute lymphocytic leukemia (T-ALL) and adult T-cell lymphoma (ATL). T cells are often implicated in transplant rejection, and their surface receptors are pharmacologic targets for anti-rejection drugs. Additionally, there are several different T-cell disorders, including, thymic aplasia (DiGeorge syndrome), IL-12 receptor deficiency, autosomal dominant hyper-IgE syndrome (Job syndrome), and chronic mucocutaneous candidiasis. See clinical significance for further explanation.</p>
      </sec>
      <sec id="article-29847.s3" sec-type="Structure">
        <title>Structure</title>
        <p>All T lymphocytes have the TCR (T-cell receptor) and the pan-T-cell co-receptor CD3. It recognizes the antigen-loaded MHC molecules on other cells. Whether it can recognize MHC 1 or MHC 2 depends on its co-receptor (rather CD4 or CD8) as previously discussed. The TCR itself is a transmembrane receptor made up of various alpha and beta chains, each with variable regions. These variations develop to recognize different antigens and become selected for during the T-cell maturation process (involving positive and negative selection, within the thymus).<xref ref-type="bibr" rid="article-29847.r1">[1]</xref><xref ref-type="bibr" rid="article-29847.r2">[2]</xref> A small portion of T cells in the body have delta and gamma chains and recognize different antigen types than other T cells. These cells are a unique subpopulation called gamma-delta T cells and reside mostly in the mucosal epithelial layers of the body.<xref ref-type="bibr" rid="article-29847.r3">[3]</xref> T cells also have various chemokine/co-receptors on their surfaces. The CCR5 and CXCR4 (found mostly on CD4+ T cells) chemokine receptors are of particular importance because they are the targets of HIV.<xref ref-type="bibr" rid="article-29847.r4">[4]</xref><xref ref-type="bibr" rid="article-29847.r5">[5]</xref></p>
        <p>The other structural markers of T cells depend on the T-cell type in question. CD4+ T cells have CD4, whereas CD8+ T cells have CD8 as an added co-receptor. T regulatory cells have CD4, and CD25 added as co-receptors for their TCRs. As mentioned above, T cells have numerous other biochemical receptors on their surface, and these largely depend on the T cell's function.<xref ref-type="bibr" rid="article-29847.r1">[1]</xref><xref ref-type="bibr" rid="article-29847.r6">[6]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-29847.s4" sec-type="Function">
        <title>Function</title>
        <p>T-cell function is dependent on the type of&#x000a0;T cell. The major T cells are CD8+ T cells, CD4+ T cells, and T regulatory cells (i.e., suppressor T cells). Several other minor types of T cells exist that are beyond this article.&#x000a0;</p>
        <p>CD8+ T cells, also known as killer T cells (or cytotoxic T cells), are effector cells for cell-mediated immunity. Initially, CD8+ T cells are naive and must be activated to begin effector functions (i.e., immune functions). This activation occurs by interaction with pro-APCs (&#x0201c;professional&#x0201d; antigen-presenting cells), mainly dendritic cells in lymph nodules/follicles, and leads to an intracellular pathway that up-regulates more antigen-specific TCRs on the T cell and leads to effector functions. T cells can only recognize protein-based antigens. TCRs (T-cell receptor and their co-receptors, such as CD3 and CD8) found on these cells form a complex with the MHC 1 receptor and the antigen in question. Once an activated CD8+ migrates into circulation and finds its antigenic target (expressed on a virally infected cell or cell with intracellular bacteria, for example), it utilizes its killing function.<xref ref-type="bibr" rid="article-29847.r1">[1]</xref> The killing function of CD8+ T cells is mediated by 1 of 2 mechanisms. The first mechanism involves the use of the Fas/Fas Ligand (FasL). Activated CD8+ T cells express FasL which binds to Fas (CD95), a receptor found on many cell types, leading to the activation of caspases and subsequent apoptosis of the target cell (often a cell infected with intracellular bacteria, such as <italic toggle="yes">Listeria</italic> species or a virally infected cell). The second method that activated CD8+ T cells can use for their killing function involves the release of granzymes and perforin (two compounds that bypass cell walls and active caspases). Activated CD8+ T cells also secrete IFN-? (a cytokine used in the activation of macrophages/other immune processes).<xref ref-type="bibr" rid="article-29847.r5">[5]</xref><xref ref-type="bibr" rid="article-29847.r7">[7]</xref></p>
        <p>CD4+ T cells, also known as helper T cells, are effector cells for cell-mediated immunity. Initially, CD4+ T cells are na&#x000ef;ve and must be activated to begin effector functions (i.e., immune functions). This activation occurs by interaction with pro-APCs (&#x0201c;professional&#x0201d; antigen-presenting cells), mainly dendritic cells in lymph nodules/follicles, which leads to an intracellular pathway that up-regulates more antigen-specific TCRs on the T cell and leads to effector functions. T cells can only recognize protein-based antigens. TCRs (T cell receptor and their co-receptors, such as CD3 and CD4) found on these cells form a complex with the MHC 2 receptor and the antigen in question. The CD4+ cells are then activated and produce cytokines to initiate immune responses from other white blood cells/other immune cells of cell-mediated immunity. They also activate the T cell-dependent branch of humoral immunity, in which CD4+ T cells recognize protein antigens (which normally would elicit a weak or absent B cell response) and activate B cells to produce immunoglobulin in response to the antigen.<xref ref-type="bibr" rid="article-29847.r8">[8]</xref><xref ref-type="bibr" rid="article-29847.r9">[9]</xref></p>
        <p>There are three different subtypes of CD4+ T cells, each with a unique function: TH1 CD4+ T cells, TH2 CD4+ T cells, and TH17 CD4+ T cells. TH1 CD4+ cells are important in the activation of macrophages and fighting off intracellular infections. They secrete the cytokine IFN-gamma which activates macrophages, B cells (to produce IgG) and increased surface expression of the MHC 2 markers on macrophages/antigen-presenting cells. TNF-a is also secreted by these cells to activate dendritic cell migration. The activated macrophages then produced IL-12, which increases differentiation/production of TH1 T cells, further amplifying the immune response. TH1 T cells also play roles in several autoimmune reactions and disease, notably in delayed-type hypersensitivity (DTH). TH2 CD4+ T cells are important in combating helminthic infections. These T cells produce IL-4, IL-5, and IL-13, which activate and expand mast cells and eosinophils to clear the parasitic infection.<xref ref-type="bibr" rid="article-29847.r10">[10]</xref><xref ref-type="bibr" rid="article-29847.r11">[11]</xref> Macrophages are also activated by these cells to begin clear of cellular debris and inflammation caused by large parasites. TH2 cells also appear to play a role in allergic diseases/allergies. TH17 CD4+ T cells are vital in mucosal immunity and are involved in combating extracellular bacteria, and fungi. TH17 cells produce IL17A, IL17F, and IL-22. These cytokines activate neutrophils and monocytes as well as driving increased inflammation. It is this pro-inflammatory function that appears to play a role in the development of autoimmune inflammatory disorders (such as inflammatory bowel disease and rheumatoid arthritis) when the response is pathogenic.<xref ref-type="bibr" rid="article-29847.r12">[12]</xref><xref ref-type="bibr" rid="article-29847.r13">[13]</xref><xref ref-type="bibr" rid="article-29847.r14">[14]</xref></p>
        <p>The last major type of T cells is the T regulatory cell (also known as suppressor T cells). These cells modulate immune responses and inhibit autoimmune processes (such as autoreactive immune cells). T regulatory cells produce inhibitory IL-10 and IL-35 cytokines to control immune responses, as well as using CTLA-4 to inhibit B7 on antigen-presenting cells to decrease immune responses. Production of T regulatory cells is spurred by cytokine IL-2 (so much so that in autoimmune disease IL-2 is often absent) and TGF-beta. T regulatory cells express the TCR (CD3), CD4 (they likely share a common lineage with CD4+ Helper T cells), CTLA-4 and CD25. They also express the biomarker FOXP3 (a transcription marker important in their development and immune functions). There has been a recent interest in T regulatory cells as a method to promote wound healing after surgery and to battle cancers.<xref ref-type="bibr" rid="article-29847.r14">[14]</xref><xref ref-type="bibr" rid="article-29847.r15">[15]</xref></p>
      </sec>
      <sec id="article-29847.s5" sec-type="Tissue Preparation">
        <title>Tissue Preparation</title>
        <p>Normally, specimens are prepared with hematoxylin and eosin stain unless obtaining the sample for specific purposes. See the Light Microscopy, Structure, Histochemistry, and EM microscopy sections for further details.</p>
      </sec>
      <sec id="article-29847.s6" sec-type="Histochemistry and Cytochemistry">
        <title>Histochemistry and Cytochemistry</title>
        <p>The primary histochemistry markers for T cells are their various surface receptors and signaling molecules. These markers have previously been discussed in the other sections. All T lymphocytes have the TCR and the pan-T cell co-receptor CD3. CD4+ T cells have CD4, whereas CD8+ T cells have CD8 as an added co-receptor. T regulatory cells have CD4, and CD25 added as co-receptors for their TCRs. Various chemokine receptors can also serve as T-cell markers, based on their respective functions. The CCR5 and CXCR4 (found mostly on CD4+ T cells) chemokine receptors are of particular importance because they are the targets of HIV.<xref ref-type="bibr" rid="article-29847.r2">[2]</xref><xref ref-type="bibr" rid="article-29847.r4">[4]</xref></p>
      </sec>
      <sec id="article-29847.s7" sec-type="Microscopy, Light&#x0000d;&#x0000a;">
        <title>Microscopy, Light
</title>
        <p>There is no way to differentiate between types of lymphocytes (B and T cells) under light microscopy; instead, flow cytometry (identifying surface markers) is used. Lymphocytes under a light microscope are about the size of a red blood cell, around 7 micrometers, though some variation is expected. These cells have large, dark-staining nuclei (taking up most of the cell) due to having a lot of condensed chromatin. There is often only a small amount of pale, blue cytoplasm notable in these cells.<xref ref-type="bibr" rid="article-29847.r16">[16]</xref></p>
      </sec>
      <sec id="article-29847.s8" sec-type="Microscopy, Electron&#x0000d;&#x0000a;">
        <title>Microscopy, Electron
</title>
        <p>Electron microscopy of lymphocytes shows many prominent polyribosomes. Some note that&#x000a0;it is possible to differentiate between T and B cells under EM, with T cells having an electron-dense cytoplasm and euchromatin nucleus. Some studies have also noted that on surface examination, T cells have a smoother surface than B cells. There is no way to differentiate the types of&#x000a0;T cells.<xref ref-type="bibr" rid="article-29847.r16">[16]</xref></p>
      </sec>
      <sec id="article-29847.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>T-cell dysfunction is notable in several types of immunodeficiencies and autoimmune diseases, both acquired and genetic. Notably, T cells are the main targets of HIV and HTLV. T cells are also implicated in several types of neoplasms, such as T-cell acute lymphocytic leukemia (T-ALL) and adult T-cell lymphoma (ATL). T cells are often implicated in transplant rejection, and their surface receptors are pharmacologic targets for anti-rejection drugs.</p>
        <p>T cells are specifically affected by several immunodeficiency disorders. Bare lymphocyte syndrome is an immunodeficiency in which T cells become selectively lost due to impaired MHC expression (due to genetic mutations in MHC production/expression). DiGeorge syndrome is another disorder that impacts T cells as the thymus never forms, and thus T cells are never properly matured due to a deletion of the 22q11.21 through 22q11.23 chromosomal arms. Wiskott-Aldrich syndrome is an X-linked recessive disease in which the immune synapse is disordered, and T cells cannot react to foreign antigens. Various ZAP-70 and CD3 mutations impair TCR formation/function and cause T cell dysfunction too. Combined immunodeficiency&#x02019;s (in which both B and T cells are affected) such as SCID and JAK3 deficiency also impair T cell function.<xref ref-type="bibr" rid="article-29847.r17">[17]</xref><xref ref-type="bibr" rid="article-29847.r18">[18]</xref></p>
        <p>Type IV hypersensitivity (delayed-type hypersensitivity, also known as DTH), is CD4+ T cell-mediated and&#x000a0;is implicated in contact dermatitis and granuloma formation and the basis for the tuberculin skin test. Systemic lupus erythematosus (SLE) is an autoimmune disorder in which autoreactive CD4+ T cells lead to the&#x000a0;production of autoreactive antibodies (via B cell activation). A similar reaction occurs in rheumatoid arthritis (RA), in which autoreactive CD4+ TH17 and TH1 cells release autoreactive cytokines causing joint inflammation. IPEX is an autoimmune disorder in which <italic toggle="yes">FOPX3</italic> mutations cause a loss of function in T regulatory cells and uninhibited T-cell activation, leading to widespread inflammation.<xref ref-type="bibr" rid="article-29847.r18">[18]</xref><xref ref-type="bibr" rid="article-29847.r19">[19]</xref></p>
        <p>HIV targets CD4+ T cells by binding to the CCR5 and CXCR4 chemokine receptors to infect them. Some note that in individuals with mutations to these receptors, there is some&#x000a0;immunity to HIV, due to HIV using them as its portal of cell entry. Human T-cell lymphotropic virus (HTLV) also specifically targets CD4+ T cells, using them to replicate. HTLV appears to use the adhesion molecules (used to migrate throughout the body by T cells) on cells surface to gain entry and replicate. HTLV infection eventually leads to the development of adult T-cell leukemia/lymphoma (ATL). ATL results from HTLV activating NF-kappaB, which leads to unregulated T-cell replication and expansion. T-cell acute lymphocytic leukemia (T-ALL) is also a T-cell centric neoplasm, caused by an activating mutation in <italic toggle="yes">NOTCH1</italic>. T cells are also heavily implicated in extranodal T-cell lymphoma, various types of Hodgkin lymphomas and ALK + lymphomas. The type of&#x000a0;T-cell response and which subtype responds to a pathogen is essential to fight off infections caused by <italic toggle="yes">Mycobacterium</italic>&#x000a0;and <italic toggle="yes">Leishmania </italic>species, among others.<xref ref-type="bibr" rid="article-29847.r4">[4]</xref><xref ref-type="bibr" rid="article-29847.r20">[20]</xref><xref ref-type="bibr" rid="article-29847.r21">[21]</xref><xref ref-type="bibr" rid="article-29847.r22">[22]</xref></p>
        <p>T cells are often implicated in transplant rejection, and their surface receptors are pharmacologic targets for many anti-rejection drugs. There has been a recent interest in T regulatory cells as a method to promote wound healing after surgery and to battle cancers. There is research to use all forms of T cells to combat a variety of diseases/enhance immune responses.<xref ref-type="bibr" rid="article-29847.r19">[19]</xref></p>
      </sec>
      <sec id="article-29847.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29847&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29847">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29847/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29847">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29847.s11">
        <title>References</title>
        <ref id="article-29847.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lyu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ozawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hamana</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Muraguchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kishi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A novel and simple method to produce large amounts of recombinant soluble peptide/major histocompatibility complex monomers for analysis of antigen-specific human T cell receptors.</article-title>
            <source>N Biotechnol</source>
            <year>2019</year>
            <month>Mar</month>
            <day>25</day>
            <volume>49</volume>
            <fpage>169</fpage>
            <page-range>169-177</page-range>
            <pub-id pub-id-type="pmid">30465909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bentzen</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Such</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Marquard</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jessen</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Lyngaa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Koelle</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Linnemann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>TNM</given-names>
              </name>
              <name>
                <surname>Marcatili</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nghiem</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hadrup</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexes.</article-title>
            <source>Nat Biotechnol</source>
            <year>2018</year>
            <month>Nov</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">30451992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Melandri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zlatareva</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chaleil</surname>
                <given-names>RAG</given-names>
              </name>
              <name>
                <surname>Dart</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Chancellor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nussbaumer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Polyakova</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Wesch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kabelitz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Irving</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Vantourout</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hayday</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>The &#x003b3;&#x003b4;TCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness.</article-title>
            <source>Nat Immunol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>12</issue>
            <fpage>1352</fpage>
            <page-range>1352-1365</page-range>
            <pub-id pub-id-type="pmid">30420626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boyer</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Targeting Immune Checkpoint Molecules to Eliminate Latent HIV.</article-title>
            <source>Front Immunol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>2339</fpage>
            <pub-id pub-id-type="pmid">30459753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakiboneka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mugaba</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Auma</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Kintu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lindan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nanteza</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Kaleebu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Serwanga</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Interferon gamma (IFN-&#x003b3;) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.</article-title>
            <source>Vaccine</source>
            <year>2019</year>
            <month>Jan</month>
            <day>03</day>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-122</page-range>
            <pub-id pub-id-type="pmid">30459072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>[The decreased number of regulatory T cells in peripheral blood is accompanied by decreased autophagy in pediatric immune thrombocytopenia].</article-title>
            <source>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>9</issue>
            <fpage>834</fpage>
            <page-range>834-838</page-range>
            <pub-id pub-id-type="pmid">30463657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lyu</surname>
                <given-names>FL</given-names>
              </name>
            </person-group>
            <article-title>[Progress of CD8+ T cell-mediated immune response to Toxoplasma gondii infection].</article-title>
            <source>Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-7</page-range>
            <pub-id pub-id-type="pmid">25065216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nanayakkara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Drummer Iv</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tam</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Co-signaling receptors regulate T-cell plasticity and immune tolerance.</article-title>
            <source>Front Biosci (Landmark Ed)</source>
            <year>2019</year>
            <month>Jan</month>
            <day>01</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <page-range>96-132</page-range>
            <pub-id pub-id-type="pmid">30468648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourne</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Banasik</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pyles</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Sch&#x000e4;fer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Milligan</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Increased Frequency of Virus Shedding by Herpes Simplex Virus 2-Infected Guinea Pigs in the Absence of CD4<sup>+</sup> T Lymphocytes.</article-title>
            <source>J Virol</source>
            <year>2019</year>
            <month>Feb</month>
            <day>15</day>
            <volume>93</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">30463981</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Blaine</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Rayon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vel&#x000e1;zquez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Non-apoptotic Fas (CD95) Signaling on T Cells Regulates the Resolution of Th2-Mediated Inflammation.</article-title>
            <source>Front Immunol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>2521</fpage>
            <pub-id pub-id-type="pmid">30443253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yukawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miyao</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kurasawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arima</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Th2 cell differentiation from naive CD4<sup>+</sup> T cells is enhanced by autocrine CC chemokines in atopic diseases.</article-title>
            <source>Clin Exp Allergy</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>474</fpage>
            <page-range>474-483</page-range>
            <pub-id pub-id-type="pmid">30431203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Osborne</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Brar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.</article-title>
            <source>Brain Behav Immun</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>76</volume>
            <fpage>7</fpage>
            <page-range>7-16</page-range>
            <pub-id pub-id-type="pmid">30465878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kostrzewa-Nowak</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nowak</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Analysis of selected T cell subsets in peripheral blood after exhaustive effort among elite soccer players.</article-title>
            <source>Biochem Med (Zagreb)</source>
            <year>2018</year>
            <month>Oct</month>
            <day>15</day>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>030707</fpage>
            <pub-id pub-id-type="pmid">30429675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Batista-Duharte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>T&#x000e9;llez-Mart&#x000ed;nez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Roberto de Andrade</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Portuondo</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Jellmayer</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Polesi</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Carlos</surname>
                <given-names>IZ</given-names>
              </name>
            </person-group>
            <article-title>Sporothrix brasiliensis induces a more severe disease associated with sustained Th17 and regulatory T cells responses than Sporothrix schenckii sensu stricto in mice.</article-title>
            <source>Fungal Biol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>122</volume>
            <issue>12</issue>
            <fpage>1163</fpage>
            <page-range>1163-1170</page-range>
            <pub-id pub-id-type="pmid">30449354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeon</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>KI</given-names>
              </name>
            </person-group>
            <article-title>IL2 is required for functional maturation of regulatory T cells.</article-title>
            <source>Anim Cells Syst (Seoul)</source>
            <year>2017</year>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">30460045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polliack</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siegal</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Clarkson</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Winchester</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lampen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Siegal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Harven</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lymphoproliferative disorders.</article-title>
            <source>Scand J Haematol</source>
            <year>1975</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>359</fpage>
            <page-range>359-76</page-range>
            <pub-id pub-id-type="pmid">812174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Signer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Saitta</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).</article-title>
            <source>Curr Allergy Asthma Rep</source>
            <year>2018</year>
            <month>Oct</month>
            <day>30</day>
            <volume>18</volume>
            <issue>12</issue>
            <fpage>75</fpage>
            <pub-id pub-id-type="pmid">30377837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Justiz Vaillant</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Qurie</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Immunodeficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">29763203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r19">
          <label>19</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Charbonnier</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Chatila</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <chapter-title>Phenotypic and Functional Characterization of Regulatory T Cell Populations</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Soboloff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kappes</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <source>Signaling Mechanisms Regulating T Cell Diversity and Function</source>
            <publisher-name>CRC Press/Taylor &#x00026; Francis</publisher-name>
            <publisher-loc>Boca Raton (FL)</publisher-loc>
            <year>2018</year>
            <fpage>105</fpage>
            <lpage>118</lpage>
            <pub-id pub-id-type="pmid">30427630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Immunomodulatory effects of intraoperative dexmedetomidine on T helper 1, T helper 2, T helper 17 and regulatory T cells cytokine levels and their balance: a prospective, randomised, double-blind, dose-response clinical study.</article-title>
            <source>BMC Anesthesiol</source>
            <year>2018</year>
            <month>Nov</month>
            <day>08</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>164</fpage>
            <pub-id pub-id-type="pmid">30409131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Georgieva</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Non-Structural Proteins from Human T-cell Leukemia Virus Type 1 in Cellular Membranes-Mechanisms for Viral Survivability and Proliferation.</article-title>
            <source>Int J Mol Sci</source>
            <year>2018</year>
            <month>Nov</month>
            <day>08</day>
            <volume>19</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">30413005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29847.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Eom</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia.</article-title>
            <source>Ann Lab Med</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-132</page-range>
            <pub-id pub-id-type="pmid">30430774</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
